Dexmethylphenidate | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Dexmethylphenidate
HEALTH CANADA PATENTS

Evonik

Contact Supplier

Fishfa Biogenics: Renowned Manufacturer, & Exporter of Tacrolimus & Mupirocin API.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Dexmethylphenidate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

12 API Suppliers, 8 USDMF, 9 NDC API, 7 Listed Suppliers, $ API Reference Price

12 API Suppliers
8 USDMF
9 NDC API
7 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

30 Drugs in Development

30 Drugs in Development

INTERMEDIATES

2 API Suppliers

2 API Suppliers

FINISHED DOSAGE FORMULATIONS

120 FDF Dossiers, 112 FDA Orange Book, 8 Europe

120 FDF Dossiers
112 FDA Orange Book
8 Europe

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 2.5MG, TABLET;ORAL - 5MG, CAPSULE, EXTENDED RELEASE;ORAL - 10MG, CAPSULE, EXTENDED RELEASE;ORAL - 15MG, CAPSULE, EXTENDED RELEASE;ORAL - 20MG, CAPSULE, EXTENDED RELEASE;ORAL - 25MG, CAPSULE, EXTENDED RELEASE;ORAL - 30MG, CAPSULE, EXTENDED RELEASE;ORAL - 35MG, CAPSULE, EXTENDED RELEASE;ORAL - 40MG, CAPSULE, EXTENDED RELEASE;ORAL - 5MG

TABLET;ORAL - 10MG
TABLET;ORAL - 2.5MG
TABLET;ORAL - 5MG
CAPSULE, EXTENDED RELEASE;ORAL - 10MG
CAPSULE, EXTENDED RELEASE;ORAL - 15MG
CAPSULE, EXTENDED RELEASE;ORAL - 20MG
CAPSULE, EXTENDED RELEASE;ORAL - 25MG
CAPSULE, EXTENDED RELEASE;ORAL - 30MG
CAPSULE, EXTENDED RELEASE;ORAL - 35MG
CAPSULE, EXTENDED RELEASE;ORAL - 40MG
CAPSULE, EXTENDED RELEASE;ORAL - 5MG

RELATED EXCIPIENT COMPANIES

5 Evonik, 4 SPI Pharma, 2 Seqens, 8 DKSH, 11 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 4 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 18 BASF, 2 Clariant, 21 Corel Pharma Chem, 6 DFE Pharma, 3 Doshion Polyscience, 2 Finar, 7 Gangwal Chemicals, 13 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 36 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 12 Microlex e.U, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 18 Roquette, 8 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 5 The Dow Chemical Company, 2 Valens Pharmachem, 3 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

71 Fillers, Diluents & Binders, 69 Coating Systems & Additives, 50 Controlled & Modified Release, 28 Direct Compression, 27 Thickeners and Stabilizers, 19 Disintegrants & Superdisintegrants, 19 Granulation, 19 Taste Masking, 18 Lubricants & Glidants, 18 Film Formers & Plasticizers, 16 Solubilizers, 15 Co-Processed Excipients, 15 Topical, 9 Empty Capsules, 9 Parenteral, 6 Emulsifying Agents, 6 Chewable & Orodispersible Aids, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 4 API Stability Enhancers, 3 Rheology Modifiers

71 Fillers, Diluents & Binders
69 Coating Systems & Additives
50 Controlled & Modified Release
28 Direct Compression
27 Thickeners and Stabilizers
19 Disintegrants & Superdisintegrants
19 Granulation
19 Taste Masking
18 Lubricants & Glidants
18 Film Formers & Plasticizers
16 Solubilizers
15 Co-Processed Excipients
15 Topical
9 Empty Capsules
9 Parenteral
6 Emulsifying Agents
6 Chewable & Orodispersible Aids
5 Coloring Agents
4 Vegetarian Capsules
4 Surfactant & Foaming Agents
4 API Stability Enhancers
3 Rheology Modifiers

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 41 NEWS #PharmaBuzz

3 DATA COMPILATION #PharmaFlow
41 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 36 Finished Drug Prices, 6 Annual Reports

4 US Medicaid Prescriptions
36 Finished Drug Prices
6 Annual Reports

MARKET PLACE

2 APIs

2 APIs

PATENTS & EXCLUSIVITIES

18 US Patents, 3 US Exclusivities, 6 Health Canada Patents

18 US Patents
3 US Exclusivities
6 Health Canada Patents

$ API Ref.Price (USD/KG) : 6,421 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

6 All

01 6Biovail Corporation

filter Patent Reset all filters

6 All

01 32240329

02 32241611

filter Product Reset all filters

6 All

01 6Dexmethylphenidate

filter Dosage Reset all filters

6 All

01 6Tablet

filter Exp Date Reset all filters

6 All

01 32018-06-11

02 32018-06-22

Product Main Page

01

Biovail Corporation

Dexmethylphenidate

2024 ACI Convention

Not Confirmed

Biovail Corporation

Country

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-06-22

Date Granted : 2004-08-17

Dexmethylphenidate

Brand Name : ATTENADE

Patent Number : 2241611

Filing Date : 1998-06-22

Strength per Unit : 10 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-06-22

Date Granted : 2004-08-17

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Biovail Corporation

Dexmethylphenidate

2024 ACI Convention

Not Confirmed

Biovail Corporation

Country

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-06-11

Date Granted : 2004-12-28

Dexmethylphenidate

Brand Name : ATTENADE

Patent Number : 2240329

Filing Date : 1998-06-11

Strength per Unit : 2.5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-06-11

Date Granted : 2004-12-28

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Biovail Corporation

Dexmethylphenidate

2024 ACI Convention

Not Confirmed

Biovail Corporation

Country

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-06-22

Date Granted : 2004-08-17

Dexmethylphenidate

Brand Name : ATTENADE

Patent Number : 2241611

Filing Date : 1998-06-22

Strength per Unit : 2.5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-06-22

Date Granted : 2004-08-17

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Biovail Corporation

Dexmethylphenidate

2024 ACI Convention

Not Confirmed

Biovail Corporation

Country

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-06-11

Date Granted : 2004-12-28

Dexmethylphenidate

Brand Name : ATTENADE

Patent Number : 2240329

Filing Date : 1998-06-11

Strength per Unit : 5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-06-11

Date Granted : 2004-12-28

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

Biovail Corporation

Dexmethylphenidate

2024 ACI Convention

Not Confirmed

Biovail Corporation

Country

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-06-22

Date Granted : 2004-08-17

Dexmethylphenidate

Brand Name : ATTENADE

Patent Number : 2241611

Filing Date : 1998-06-22

Strength per Unit : 5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-06-22

Date Granted : 2004-08-17

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

Biovail Corporation

Dexmethylphenidate

2024 ACI Convention

Not Confirmed

Biovail Corporation

Country

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-06-11

Date Granted : 2004-12-28

Dexmethylphenidate

Brand Name : ATTENADE

Patent Number : 2240329

Filing Date : 1998-06-11

Strength per Unit : 10 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-06-11

Date Granted : 2004-12-28

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?